S.C. Cosulich
AstraZeneca Central Toxicology Laboratory
Alderley Park
Macclesfield
Cheshire SK10 4TJ and AstraZeneca Pharmaceuticals
UK
Name/email consistency: high
- Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators. Cosulich, S., James, N., Roberts, R. Carcinogenesis (2000)
- A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin. Cosulich, S.C., James, N.H., Needham, M.R., Newham, P.P., Bundell, K.R., Roberts, R.A. Carcinogenesis (2000)